SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yasemin Parlak Demir, Sibel Aksu Yıldırım, Reliability and validity of Trunk Control Test in patients with neuromuscular diseases, Physiotherapy Theory and Practice, 2015, 31, 1, 39

    CrossRef

  2. 2
    Young-Sil An, Chang-Hee Suh, Ju-Yang Jung, Hyoun-Ah Kim, Role of bone scan in the assessment of polymyositis/dermatomyositis, Clinical Rheumatology, 2015, 34, 4, 699

    CrossRef

  3. 3
    Valérie Decostre, Aurélie Canal, Gwenn Ollivier, Isabelle Ledoux, Amélie Moraux, Valérie Doppler, Christine Anne Mary Payan, Jean-Yves Hogrel, Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years, BMC Musculoskeletal Disorders, 2015, 16, 1

    CrossRef

  4. 4
    L. Iaccarino, E. Pegoraro, L. Bello, S. Bettio, E. Borella, L. Nalotto, C. Semplicini, G. Sorarù, A. Ghirardello, A. Doria, Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation, Autoimmunity Highlights, 2014, 5, 3, 87

    CrossRef

  5. 5
    Rossella Neri, Simone Barsotti, Valentina Iacopetti, Alessandra Tripoli, Anna dʼAscanio, Antonio Gaetano Tavoni, Marta Mosca, Stefano Bombardieri, Clinically Amyopathic Dermatomyositis, Journal of Clinical Neuromuscular Disease, 2014, 15, 4, 157

    CrossRef

  6. 6
    H. Sanner, I. Sjaastad, B. Flato, Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool, Rheumatology, 2014, 53, 9, 1578

    CrossRef

  7. 7
    Levente Bodoki, Melinda Nagy-Vincze, Zoltán Griger, Zoe Betteridge, Lászlóné Szöllősi, Katalin Dankó, Four dermatomyositis-specific autoantibodies—anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5—in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort, Autoimmunity Reviews, 2014, 13, 12, 1211

    CrossRef

  8. 8
    Nadia J.C. Luca, Brian M. Feldman, Health outcomes of pediatric rheumatic diseases, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 331

    CrossRef

  9. 9
    Imma Armadans-Tremolosa, Albert Selva-O’Callaghan, Bienvenido Visauta-Vinacua, Georgina Guilera, Iago Pinal-Fernández, Miquel Vilardell-Tarrés, Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy, Clinical Rheumatology, 2014, 33, 8, 1119

    CrossRef

  10. 10
    Levente Bodoki, Melinda Vincze, Zoltán Griger, Tamás Csonka, Balázs Murnyák, Andrea Kurucz, Katalin Dankó, Tibor Hortobágyi, Inclusion body myositis — a case based clinicopathological update, Central European Journal of Medicine, 2014, 9, 1, 80

    CrossRef

  11. 11
    Julie J. Paik, Andrew L. Mammen, Fredrick M. Wigley, Allan C. Gelber, Myopathy in scleroderma, its identification, prevalence, and treatment, Current Opinion in Rheumatology, 2014, 26, 2, 124

    CrossRef

  12. 12
    Lisa G. Rider, Katalin Dankó, Frederick W. Miller, Myositis registries and biorepositories, Current Opinion in Rheumatology, 2014, 26, 6, 724

    CrossRef

  13. 13
    Alison Cohen, Hannah Morrow, Gavin Cleary, Physiotherapy and rheumatological disorders, Paediatrics and Child Health, 2014, 24, 2, 83

    CrossRef

  14. 14
    Rohit Aggarwal, Andriy Bandos, Ann M. Reed, Dana P. Ascherman, Richard J. Barohn, Brian M. Feldman, Frederick W. Miller, Lisa G. Rider, Michael O. Harris-Love, Marc C. Levesque, Chester V. Oddis, Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis, Arthritis & Rheumatology, 2014, 66, 3
  15. 15
    L. Unger, S. Kampf, K. Luthke, M. Aringer, Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population, Rheumatology, 2014, 53, 9, 1630

    CrossRef

  16. 16
    Albert Selva-O’Callaghan, Manel Ramos Casals, Josep M. Grau Junyent, Terapia biológica en pacientes con miopatía inflamatoria idiopática, Medicina Clínica, 2014, 143, 6, 275

    CrossRef

  17. 17
    TCM Castro, H Lederman, MT Terreri, WI Caldana, E Zanoteli, MOE Hilário, Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients, Scandinavian Journal of Rheumatology, 2014, 43, 4, 329

    CrossRef

  18. 18
    M. Riisager, P.R. Mathiesen, J. Vissing, N. Preisler, M.C. Ørngreen, Aerobic training in persons who have recovered from juvenile dermatomyositis, Neuromuscular Disorders, 2013, 23, 12, 962

    CrossRef

  19. 19
    Nadia J. Luca, Brian M. Feldman, Disease Activity Measures in Paediatric Rheumatic Diseases, International Journal of Rheumatology, 2013, 2013, 1

    CrossRef

  20. 20
    B. Maurer, Frühsymptome der Dermatomyositis und des Antisynthetase-Syndroms, Zeitschrift für Rheumatologie, 2013, 72, 10, 970

    CrossRef

  21. 21
    B. Bader-Meunier, C. Bodemer, Lupus sistémico y dermatomiositis infantil, EMC - Pediatría, 2013, 48, 4, 1

    CrossRef

  22. 22
    B. Bader-Meunier, C. Bodemer, Lupus systémique et dermatomyosites de l’enfant, EMC - Pédiatrie - Maladies infectieuses, 2013, 8, 2, 1

    CrossRef

  23. 23
    Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris-Love, Diane C. Koontz, Noreen Fertig, Stephanie S. Kelley, Sherrie L. Pryber, Frederick W. Miller, Howard E. Rockette, Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial, Arthritis & Rheumatism, 2013, 65, 2
  24. 24
    Cécile Tolédano, Murielle Gain, Adrien Kettaneh, Bruno Baudin, Catherine Johanet, Patrick Chérin, Sébastien Rivière, Jean Cabane, Kiet Tiev, Aldolase predicts subsequent myopathy occurrence in systemic sclerosis, Arthritis Research & Therapy, 2012, 14, 3, R152

    CrossRef

  25. 25
    Jessie L. Werner, Lisa Christopher-Stine, Sharon R. Ghazarian, Katherine S. Pak, Jordan E. Kus, Natalie R. Daya, Thomas E. Lloyd, Andrew L. Mammen, Antibody levels correlate with creatine kinase levels and strength in anti–3-hydroxy-3-methylglutaryl-coenzyme A reductase–associated autoimmune myopathy, Arthritis & Rheumatism, 2012, 64, 12
  26. 26
    Ann M. Reed, Erik Peterson, Hatice Bilgic, Steven R. Ytterberg, Shreyasee Amin, Molly S. Hein, Cynthia S. Crowson, Floranne Ernste, Emily Baechler Gillespie, Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course, Arthritis & Rheumatism, 2012, 64, 12
  27. 27
    N. Martin, P. Krol, S. Smith, L. Beard, C. A. Pilkington, J. Davidson, L. R. Wedderburn, Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study, Arthritis Care & Research, 2012, 64, 11
  28. 28
    Adam M. Huber, Idiopathic Inflammatory Myopathies in Childhood: Current Concepts, Pediatric Clinics of North America, 2012, 59, 2, 365

    CrossRef

  29. 29
    P Mathiesen, H Hegaard, T Herlin, M Zak, FK Pedersen, S Nielsen, Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study, Scandinavian Journal of Rheumatology, 2012, 41, 1, 50

    CrossRef

  30. 30
    Mária Filková, Hana Hulejová, Klára Kuncová, Lenka Pleštilová, Lucie Cerezo, Heřman Mann, Martin Klein, Josef Zámečník, Steffen Gay, Jiří Vencovský, Ladislav Šenolt, Resistin in idiopathic inflammatory myopathies, Arthritis Research & Therapy, 2012, 14, 3, R111

    CrossRef

  31. 31
    Fumihito Suzuki, Tetsuo Kubota, Yasunari Miyazaki, Kinya Ishikawa, Masashi Ebisawa, Shunsei Hirohata, Takashi Ogura, Hidehiro Mizusawa, Toshio Imai, Nobuyuki Miyasaka, Toshihiro Nanki, Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity, Arthritis Research & Therapy, 2012, 14, 2, R48

    CrossRef

  32. 32
    K. Krüger, K. Karberg, „Treat-To-Target“ aus der Sicht der niedergelassenen Rheumatologie, Zeitschrift für Rheumatologie, 2011, 70, 8, 664

    CrossRef

  33. 33
    Mariana Brandão, António Marinho, Idiopathic inflammatory myopathies: Definition and management of refractory disease, Autoimmunity Reviews, 2011, 10, 11, 720

    CrossRef

  34. 34
    Lisa G. Rider, Victoria P. Werth, Adam M. Huber, Helene Alexanderson, Anand Prahalad Rao, Nicolino Ruperto, Laura Herbelin, Richard Barohn, David Isenberg, Frederick W. Miller, Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI), Arthritis Care & Research, 2011, 63, S11